Literature DB >> 12687336

HNF-6-independent differentiation of mouse embryonic stem cells into insulin-producing cells.

N Houard1, G G Rousseau, F P Lemaigre.   

Abstract

AIMS/HYPOTHESIS: Embryonic stem cells, when grown as embryoid bodies, spontaneously generate insulin-producing cells which could be used in therapy of diabetes mellitus, provided that their selection and differentiation are optimized. To achieve such optimization, one needs to know whether the differentiation of cells in embryoid bodies mimicks that of pancreatic beta cells in embryos. To address this question we verified if the differentiation of the insulin-producing cells in embryoid bodies requires Hepatocyte Nuclear Factor-6 (HNF-6), a transcription factor known to control pancreatic endocrine differentiation in embryos.
METHODS: We generated mouse Hnf6-/- embryonic stem cells and grew them as embryoid bodies. The expression of HNF-6, insulin, and transcription factors that are regulated by HNF-6 in developing pancreas was compared in wild-type and Hnf6-/- embryoid bodies.
RESULTS: No difference was observed in the expression of insulin between wild-type and Hnf6-/-embryoid bodies. In both cases insulin was expressed in the outer layer of cells, which is similar to the visceral endoderm. In wild-type embryoid bodies HNF-6 was transiently expressed in the outer layer of cells, but was not co-expressed with insulin. The expression of genes that are targets of HNF-6 in developing pancreas was unaffected in Hnf6-/-embryoid bodies. CONCLUSION/
INTERPRETATION: In contrast to the development of pancreatic beta cells, the differentiation of insulin-producing cells in embryoid bodies did not require HNF-6. Thus, the differentiation mechanism of insulin-producing cells in embryoid bodies differs from that of the beta cells and it is likely to resemble that of insulin-producing cells in the visceral endoderm.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12687336     DOI: 10.1007/s00125-003-1041-8

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  40 in total

Review 1.  Intercellular signals regulating pancreas development and function.

Authors:  S K Kim; M Hebrok
Journal:  Genes Dev       Date:  2001-01-15       Impact factor: 11.361

2.  Homeobox gene Hex is essential for onset of mouse embryonic liver development and differentiation of the monocyte lineage.

Authors:  V W Keng; H Yagi; M Ikawa; T Nagano; Z Myint; K Yamada; T Tanaka; A Sato; I Muramatsu; M Okabe; M Sato; T Noguchi
Journal:  Biochem Biophys Res Commun       Date:  2000-10-05       Impact factor: 3.575

Review 3.  From stem cells to beta cells: new strategies in cell therapy of diabetes mellitus.

Authors:  B Soria; A Skoudy; F Martín
Journal:  Diabetologia       Date:  2001-04       Impact factor: 10.122

4.  Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets.

Authors:  N Lumelsky; O Blondel; P Laeng; I Velasco; R Ravin; R McKay
Journal:  Science       Date:  2001-04-26       Impact factor: 47.728

5.  Expression of homeobox genes, including an insulin promoting factor, in the murine yolk sac at the time of hematopoietic initiation.

Authors:  K E McGrath; J Palis
Journal:  Mol Reprod Dev       Date:  1997-10       Impact factor: 2.609

6.  neurogenin3 is required for the development of the four endocrine cell lineages of the pancreas.

Authors:  G Gradwohl; A Dierich; M LeMeur; F Guillemot
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

7.  In vitro cultivation of human islets from expanded ductal tissue.

Authors:  S Bonner-Weir; M Taneja; G C Weir; K Tatarkiewicz; K H Song; A Sharma; J J O'Neil
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

Review 8.  Genetically engineered pancreatic beta-cell lines for cell therapy of diabetes.

Authors:  S Efrat
Journal:  Ann N Y Acad Sci       Date:  1999-06-18       Impact factor: 5.691

9.  Endoderm-specific gene expression in embryonic stem cells differentiated to embryoid bodies.

Authors:  K Abe; H Niwa; K Iwase; M Takiguchi; M Mori; S I Abé; K Abe; K I Yamamura
Journal:  Exp Cell Res       Date:  1996-11-25       Impact factor: 3.905

10.  Nicotinamide is a potent inducer of endocrine differentiation in cultured human fetal pancreatic cells.

Authors:  T Otonkoski; G M Beattie; M I Mally; C Ricordi; A Hayek
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

View more
  5 in total

Review 1.  Deriving and identifying hepatocytes from embryonic stem cells.

Authors:  Alistair J Watt; Lesley M Forrester
Journal:  Stem Cell Rev       Date:  2006       Impact factor: 5.739

Review 2.  Insulin-producing surrogate β-cells from embryonic stem cells: are we there yet?

Authors:  Ortwin Naujok; Chris Burns; Peter M Jones; Sigurd Lenzen
Journal:  Mol Ther       Date:  2011-08-09       Impact factor: 11.454

3.  Glucose responsive insulin production from human embryonic germ (EG) cell derivatives.

Authors:  Gregory O Clark; Robert L Yochem; Joyce Axelman; Timothy P Sheets; David J Kaczorowski; Michael J Shamblott
Journal:  Biochem Biophys Res Commun       Date:  2007-03-12       Impact factor: 3.575

4.  In vivo characterization of transplanted human embryonic stem cell-derived pancreatic endocrine islet cells.

Authors:  A Eshpeter; J Jiang; M Au; R V Rajotte; K Lu; J S Lebkowski; A S Majumdar; G S Korbutt
Journal:  Cell Prolif       Date:  2008-12       Impact factor: 6.831

Review 5.  Mesenchymal stem cells: biology and clinical potential in type 1 diabetes therapy.

Authors:  Meng Liu; Zhong Chao Han
Journal:  J Cell Mol Med       Date:  2008-02-24       Impact factor: 5.310

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.